CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Avai Bio Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Avai Bio Inc
c/o Eastbiz.com, Inc, 5348 Vegas Drive
Phone: (702) 509-1747p:702 509-1747 LAS VEGAS, NV  89108  United States Ticker: AVAIAVAI
Business Summary
Avai Bio, Inc., formerly Avant Technologies, Inc., is a biotechnology company focused on identifying genetically modified cell lines, and through joint venture and licensing agreements developing cell-based therapies. The Company has two development programs in its cellular therapies pipeline, a diabetes development program to advance a treatment for type 1 and type 2 insulin-dependent diabetes, and an a-Klotho protein development program to advance therapies for age-related diseases and anti-aging treatments. It has secured Joint Venture and Licensing Agreements to develop both cell lines. Its diabetes program is focused on developing an insulin-producing cell line, then encapsulating those cells inside using SGAustria's Cell-in-a-Box technology to create a bio-artificial pancreas for type 1 and insulin-dependent type 2 diabetes. The Company is partnering with biotech firms, universities, scientists, and clinicians to uncover solutions for diverse healthcare challenges.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20253/31/2025YesYes--Yes

Industries
SIC Code Description
7374 Computer processing and data preparation and processing services
7375 Information retrieval services
7372 Prepackaged software

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Director IvanLunegov 40 11/24/2023 11/9/2022
President, Treasurer, Secretary & Director NatalijaTunevic
Chief Executive Officer ChrisWinter 62 11/7/2024 11/7/2024
Chief Financial Officer, Treasurer, Director VitalisRacius 43 9/9/2024 6/29/2022
Secretary NatalijaTunevic 66 10/1/2023 11/6/2017

Business Names
Business Name
AVAI
Avant! AI™
FRCK
FRCKD
InstantFAME™
TREN

General Information
Outstanding Shares: 138,252,252 (As of 2/12/2026)
Shareholders: 117
Stock Exchange: OTC
Federal Tax Id: 384053064
Fax Number: (702) 872-2060


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, March 14, 2026